Researcher
Hannelore Denys
- Keywords:Clinical trials, Fundamental and translational research, Uterine cancer, cervical cancer, Breast cancer, Ovarian cancer
- Disciplines:Cancer diagnosis, Cancer epidemiology, Oncology not elsewhere classified, Cancer therapy, Cancer biology
Affiliations
- Board of Governors/Executive Board (Administrative office)
Member
From1 Oct 2022 → Today - Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Oct 2011 → 30 Sep 2018
Projects
1 - 10 of 11
- Chitinase 3-like 1 as novel immunotherapeutic target in triple-negative breast cancerFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- PRIMMO trial - Extracellular vesicles to predict response to checkpoint inhibitors in cervical and endometrial cancer patientsFrom1 Jan 2021 → 31 Dec 2021Funding: Nonprofit institution or equivalents
- Analyzing circulating bacterial extracellular vesicles in cancer patients to identify their composition and biomarker potential.From1 Nov 2020 → 31 Mar 2023Funding: FWO fellowships
- Preclinical validation of novel anti-EMT therapy for malignant triple negative breast cancerFrom1 Mar 2020 → TodayFunding: Nonprofit institution or equivalents
- EV-TRACE: Extracellular Vesicle Tracking using surface proteins and Resonance Assays to detect breast Cancer in Early stageFrom1 Jan 2020 → 31 Dec 2023Funding: FWO Strategic Basic Research (SBO)
- Heading towards an in vivo predictive test for personalized ovarian cancer treatment: application of novel therapies in zebrafish patient derived xenograftsFrom1 Nov 2019 → TodayFunding: FWO Strategic Basic Research Grant
- Impact of vaginal morbidity on sexual functioning in cervical cancer patients treated with neo-adjuvant chemotherapy followed by surgery.From1 Jan 2019 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- beurs EVDS Sofie Van Dorpe: Extracellular vesicles as blood-based biomarker for early stage ovarian cancerFrom1 Oct 2018 → 30 Sep 2019Funding: Foundations, funds and other with scientific goal
- Targeting cancer-associated fibroblasts to overcome immunosuppressive mechanisms in mismatch repair-deficient tumorsFrom1 Oct 2018 → 30 Sep 2022Funding: FWO fellowships
- Combination of radiotherapy, PD-1 blockade and an immune-modulatory cocktail to combat cervical and uterine cancerFrom1 Jan 2017 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
Publications
21 - 30 of 125
- Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer : results from the IPSOC-mamma study(2021)Volume: 81
Authors: Veerle Foulon, Carrie Visser, Sandra De Coster, Lise-Marie Kinnaer, Ellen Reynders, Anne Deblander, Patrick Berteloot, Kevin Punie, Hans Wildiers, Veronique Cocquyt, et al.
Number of pages: 1 - Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditions(2021)
Authors: Glenn Vergauwen, Joeri Tulkens, Francisco Avila Cobos, Marie-Angélique De Scheerder, Ilkka Miinalainen, Pieter Mestdagh, Hannelore Denys, An Hendrix
- Standard of care in 2021 for patients with ovarian cancer in Belgium(2021)
Authors: Ignace Vergote, Hannelore Denys, Jacques De Grève, Christine Gennigens, Koen Van de Vijver, Joseph Kerger, Peter Vuylsteke, Jean-Francois Baurain
Pages: 286 - 291 - Reducing overall treatment time, a pilot RCT of neo-adjuvant radiotherapy in early breast cancer(2021)Volume: 161
Authors: Vincent Vakaet, Hans Van Hulle, Wilfried De Neve, Hannelore Denys
Pages: S911 - S912 - Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma(2021)Volume: 32
Authors: Emiel De Jaeghere, Sandra Tuyaerts, Ann M.T. Van Nuffel, An Hendrix, P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, A. De Caluwe, et al.
Pages: S1449 - S1450 - Debulking and HIPEC for ovarian cancer : effects of perfusion temperature on morbidity and cisplatin pharmacokinetics(2021)Volume: 47
Authors: Jesse Demuytere, Charlotte Carlier, Wouter Willaert, Philippe Tummers, Hannelore Denys, Olivier Van Kerschaver, Joseph Weerts, Sarah Cosyns, Wim Ceelen
Pages: e29 - e29 - Automated liquid handling for highly specific and reproducible density‐based separation of extracellular vesicles from human body fluids(2021)Volume: 10
Authors: Hannelore Denys, An Hendrix
Number of pages: 1 - Isolation and engraftment of circulating tumor cells into zebrafish embryos to predict tumor response of ovarian cancer patients(2020)Volume: 26
Authors: Charlotte Fieuws, Jeroen Vierstraete, Koen Van de Vijver, Hannelore Denys, Kathleen Claes
Pages: 82 - 82 - Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma(2020)
Authors: Elien De Thaye, Koen Van de Vijver, Joni Van der Meulen, Joachim Taminau, Glenn Wagemans, Hannelore Denys, Jo Van Dorpe, Geert Berx, Wim Ceelen, Jan Van Bocxlaer, et al.
- Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients(2020)
Authors: Hans Van Hulle, Vincent Vakaet, Giselle Post, Annick Van Greveling, Christel Monten, An Hendrix, Koen Van de Vijver, Jo Van Dorpe, Pieter De Visschere, Geert Braems, et al.